Open AccessAre Patients Getting Their Aspirin's Worth in Ischemic Stroke?
Author(s) -
Schmaier Alec A.,
Bhatt Deepak L.
Publication year - 2018
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.118.009564
Subject(s) - medicine , aspirin , stroke (engine) , ischemic stroke , cardiology , ischemia , mechanical engineering , engineering
Given its long history, established safety profile, and efficacy, low‐dose aspirin remains the major antiplatelet therapy utilized in secondary prevention. Recurrent ischemic events occur despite prescription of antiplatelet therapy. Residual platelet activation following agonist stimulation can